ArticleCancers2026

Real-World Outcomes of Lenvatinib in Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Multicentre Retrospective Study.

Wing-Lok Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.